1. Home
  2. NVAX vs LNN Comparison

NVAX vs LNN Comparison

Compare NVAX & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • LNN
  • Stock Information
  • Founded
  • NVAX 1987
  • LNN 1954
  • Country
  • NVAX United States
  • LNN United States
  • Employees
  • NVAX N/A
  • LNN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • LNN Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • LNN Industrials
  • Exchange
  • NVAX Nasdaq
  • LNN Nasdaq
  • Market Cap
  • NVAX 1.3B
  • LNN 1.5B
  • IPO Year
  • NVAX 1995
  • LNN 1988
  • Fundamental
  • Price
  • NVAX $6.00
  • LNN $124.06
  • Analyst Decision
  • NVAX Buy
  • LNN Hold
  • Analyst Count
  • NVAX 6
  • LNN 1
  • Target Price
  • NVAX $17.83
  • LNN $128.00
  • AVG Volume (30 Days)
  • NVAX 6.0M
  • LNN 114.0K
  • Earning Date
  • NVAX 05-09-2025
  • LNN 04-03-2025
  • Dividend Yield
  • NVAX N/A
  • LNN 1.16%
  • EPS Growth
  • NVAX N/A
  • LNN 12.44
  • EPS
  • NVAX N/A
  • LNN 7.03
  • Revenue
  • NVAX $682,162,000.00
  • LNN $647,542,000.00
  • Revenue This Year
  • NVAX $1.07
  • LNN $11.29
  • Revenue Next Year
  • NVAX N/A
  • LNN $3.37
  • P/E Ratio
  • NVAX N/A
  • LNN $17.65
  • Revenue Growth
  • NVAX N/A
  • LNN 0.46
  • 52 Week Low
  • NVAX $3.81
  • LNN $109.27
  • 52 Week High
  • NVAX $23.86
  • LNN $140.26
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.41
  • LNN 45.62
  • Support Level
  • NVAX $5.01
  • LNN $114.81
  • Resistance Level
  • NVAX $6.58
  • LNN $129.26
  • Average True Range (ATR)
  • NVAX 0.65
  • LNN 5.61
  • MACD
  • NVAX 0.02
  • LNN 0.20
  • Stochastic Oscillator
  • NVAX 50.25
  • LNN 46.04

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: